These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30503261)

  • 1. β Cell Replacement after Gene Editing of a Neonatal Diabetes-Causing Mutation at the Insulin Locus.
    Ma S; Viola R; Sui L; Cherubini V; Barbetti F; Egli D
    Stem Cell Reports; 2018 Dec; 11(6):1407-1415. PubMed ID: 30503261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes.
    Balboa D; Saarimäki-Vire J; Borshagovski D; Survila M; Lindholm P; Galli E; Eurola S; Ustinov J; Grym H; Huopio H; Partanen J; Wartiovaara K; Otonkoski T
    Elife; 2018 Nov; 7():. PubMed ID: 30412052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Activating STAT3 Mutation Causes Neonatal Diabetes through Premature Induction of Pancreatic Differentiation.
    Saarimäki-Vire J; Balboa D; Russell MA; Saarikettu J; Kinnunen M; Keskitalo S; Malhi A; Valensisi C; Andrus C; Eurola S; Grym H; Ustinov J; Wartiovaara K; Hawkins RD; Silvennoinen O; Varjosalo M; Morgan NG; Otonkoski T
    Cell Rep; 2017 Apr; 19(2):281-294. PubMed ID: 28402852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-edited human stem cell-derived β cells from a patient with monogenic diabetes reverse preexisting diabetes in mice.
    Maxwell KG; Augsornworawat P; Velazco-Cruz L; Kim MH; Asada R; Hogrebe NJ; Morikawa S; Urano F; Millman JR
    Sci Transl Med; 2020 Apr; 12(540):. PubMed ID: 32321868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
    Millette K; Georgia S
    Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
    Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
    J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
    Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
    Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes.
    Zhu Z; Li QV; Lee K; Rosen BP; González F; Soh CL; Huangfu D
    Cell Stem Cell; 2016 Jun; 18(6):755-768. PubMed ID: 27133796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Splicing of
    Panova AV; Klementieva NV; Sycheva AV; Korobko EV; Sosnovtseva AO; Krasnova TS; Karpova MR; Rubtsov PM; Tikhonovich YV; Tiulpakov AN; Kiselev SL
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
    Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
    Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.
    Wang L; Huang Y; Guo Q; Fan X; Lu Y; Zhu S; Wang Y; Bo X; Chang X; Zhu M; Wang Z
    Diabetes Res Clin Pract; 2014 Jun; 104(3):383-92. PubMed ID: 24794627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
    Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
    J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
    Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
    Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
    Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
    Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent neonatal diabetes-causing insulin mutations have dominant negative effects on beta cell identity.
    Zhang Y; Sui L; Du Q; Haataja L; Yin Y; Viola R; Xu S; Nielsson CU; Leibel RL; Barbetti F; Arvan P; Egli D
    Mol Metab; 2024 Feb; 80():101879. PubMed ID: 38237895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
    Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
    Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.